대한의생명과학회지 (Biomedical Science Letters)

  • 제25권4호
  • /
  • Pages.390-397
  • /
  • 2019
  • /
  • 1738-3226(pISSN)
  • /
  • 2288-7415(eISSN)
대한의생명과학회 (The Korean Society for Biomedical Laboratory Sciences)
권호 표지
DOI QR코드

DOI QR Code

Prevalence of Sexually Transmitted Pathogen Coinfections in High Risk-Human Papillomaviruses Infected Women in Busan

  • Choi, Sun Hee (Department of Laboratory Medicine, i-Angel Women's Clinic) ;
  • Jin, Hyunwoo (Department of Clinical Laboratory Science, College of Health Sciences, Catholic University of Pusan) ;
  • Lee, Kyung Eun (Department of Clinical Laboratory Science, College of Health Sciences, Catholic University of Pusan)
  • 투고 : 2019.10.30
  • 심사 : 2019.11.27
  • 발행 : 2019.12.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

High risk-human papillomavirus (HR-HPV) is known to be a major cause of cervical cancer, and coinfection of sexually transmitted pathogen (STP) has been reported to cause persistent HPV infection. However, the relationship between HPV and STP coinfection remains unclear. The purpose of this study was to analyze the coinfection rate with STP in high-risk human papillomavirus infected women in Busan and to collect basic data for the prevention of cervical lesions. This study was carried out in 355 women who had concurrent HPV and STP screening at Busan local hospital between January 2016 and December 2017. HPV and STP coinfection was found in 187 (52.7%) out of 355 cases. HR-HPV and STP coinfection was 82.9% higher than LR-HPV and STP coinfections 17.1%. In HR-HPV infection, Ureaplasma species was the most common pathogen (47.1%), followed by C. trachomatis (21.9%) and Mycoplasma species (12.3%). In the analysis of HR-HPV genotype according to STP, HPV 16 (12.0%) was the most frequent, followed by HPV 58 (11.6%), HPV 39 (11.1%) and HPV 52 (10.2%), but HPV 18 showed a low coinfection rate of 1.3%. According to the results of age, HR-HPV and STP coinfection rate was the highest at 41.9% among women aged 18 to 29. HR-HPV and Ureaplasma species showed the highest coinfection rates at all ages, followed by C. trachomatis and Mycoplasma species. Further studies with more samples will be needed to determine if the coinfection of HR-HPV and STPs is involved in the development of cervical tumors through histologic changes.

키워드

참고문헌

  1. Ahdieh L, Klein RS, Burk R, Cu-Uvin S, Schuman P, Duerr A, Safaeian M, Astemborski J, Daniel R, Shah K. Prevalence, incidence, and type specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV negative women. J Infect Dis. 2001. 184: 682-690. https://doi.org/10.1086/323081
  2. Bellaminutti S, Seraceni S, De Seta F, Gheit T, Tommasino M, Comar M. HPV and Chlamydia trachomatis co-detection in young asymptomatic women from high incidence area for cervical cancer. J Med Virol. 2014. 86: 1920-1925. https://doi.org/10.1002/jmv.24041
  3. Camporiondo MP, Farchi F, Ciccozzi M, Denaro A, Gallone D, Maracchioni F, Favalli C, Ciotti M. Detection of HPV and co-infecting pathogens in healthy Italian women by multiplex real-time PCR. Infez Med. 2016. 24: 12-17.
  4. Castellsague X, Bosch FX, Munoz N. Environmental co-factors in HPV carcinogenesis. Virus Res. 2002. 89: 191-199. https://doi.org/10.1016/S0168-1702(02)00188-0
  5. Ekiel AM, Friedek DA, Romanik MK, JozwiakJ, Martirosian G. Occurrence of Ureaplasma parvum and Ureaplasma urealyticum in women with cervical dysplasia in Katowice, Poland. J Korean Med Sci. 2009. 24: 1177-1181. https://doi.org/10.3346/jkms.2009.24.6.1177
  6. Ji YI. Co-infections with human papillomavirus and Mycoplasma/Ureaplasma spp. in women with abnormal cervical cytology. Gynaecol Obstet. 2017. 1: 1-3.
  7. Kim HS, Kim TJ, Lee IH, Hong SR. Associations between sexually transmitted infections, high-risk human papillomavirus infection, and abnormal cervical Pap smear results in OB/GYN outpatients. J Gynecol Oncol. 2016. 27: e49. https://doi.org/10.3802/jgo.2016.27.e49
  8. Kim SI, Yoon JH, Park DC, Lee DS, Lee SJ, Choe HS, Kim JH, Park TC, Lee SJ. Co-infection of Ureaplasma urealyticum and human papilloma virus in asymptomatic sexually active individuals. Int J Med Sci. 2018. 15: 915-920. https://doi.org/10.7150/ijms.26523
  9. Liu J, Liu W, Liu Y, Zhou X, Zhang Z, Sun Z. Prevalence of microorganisms co-infections in human papillomaviruses infected women in Northern China. Arch Gynecol Obstet. 2016. 293: 595-602. https://doi.org/10.1007/s00404-015-3826-7
  10. Ljubin-Sternak S, Mestrovic T. Chlamydia trachomatis and genital Mycoplasmas: pathogens with an impact on human reproductive health. J Pathog. 2014. 183167. https://doi.org/10.1155/2014/183167
  11. Magana-Contreras M, Contreras-Paredes A, Chavez-Blanco A, Lizzano M, De la Cruz-Hernandez Y, De la Cruz-Hernandez E. Prevalence of sexually transmitted pathogens associated with HPV infection in cervical samples in a Mexican population. J Med Virol. 2015. 87: 2098-2105. https://doi.org/10.1002/jmv.24278
  12. Markowska J, Fischer N, Filas V, Fischer Z, Breborowicz J, Markowski M. The role of Chlamydia trachomatis infection in cervical cancer development. Eur J Gynaecol Oncol. 1999. 20: 144-146.
  13. Markowska J, Fischer N, Fischer Z, Warchol JB. Chlamydia trachomatis infection in women with CIN and invasive uterine cervix cancer. Significance of hormonal status. Eur J Gynaecol Oncol. 2002. 23: 511-513.
  14. Moreno V, Bosch FX, Munoz N, Meijer CJ, Shah KV, Walboomers JM, Herrero R, Franceschi S. Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection. The Lancet. 2002. 359: 1085-1092. https://doi.org/10.1016/S0140-6736(02)08150-3
  15. Paavonen J. Chlamydia trachomatis infections of the female genital tract: state of the art. Ann Med. 2012. 44: 18-28. https://doi.org/10.3109/07853890.2010.546365
  16. Paba P, Bonifacio D, Di Bonito L, Ombres D, Favalli C, Syrjanen K, Ciotti M. Co-expression of HSV2 and Chlamydia trachomatis in HPV-positive cervical cancer and cervical intraepithelial neoplasia lesions is associated with aberrations in key intracellular pathways. Intervirology. 2008. 51: 230-234. https://doi.org/10.1159/000156481
  17. Parthenis C, Panagopoulos P, Margari N, Kottaridi C, Spathis A, Pouliakis A, Konstantoudakis S, Chrelias G, Chrelias C, Papantoniou N, Panayiotides IG, Tsiodras S. The association between sexually transmitted infections, human papillomavirus, and cervical cytology abnormalities among women in Greece. International Journal of Disease. 2018. 73: 72-77.
  18. Plummer M, Herrero R, Franceschi S, Meijer CJ, Snijders P, Bosch FX, de Sanjose S, Munoz N; IARC Multi-centre Cervical Cancer Study Group. Smoking and cervical cancer: pooled analysis of the IARC multi-centric case--control study. Cancer Causes Control. 2003. 14: 805-814. https://doi.org/10.1023/B:CACO.0000003811.98261.3e
  19. Samoff E, Koumans EH, Markowitz LE, Sternberg M, Sawyer MK, Swan D, Papp JR, Black CM, Unger ER. Association of Chlamydia trachomatis with persistence of high-risk types of human papillomavirus in a cohort of female adolescents. Am J Epidemiol. 2005. 162: 668-675. https://doi.org/10.1093/aje/kwi262
  20. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell. 1990. 63: 1129-1136. https://doi.org/10.1016/0092-8674(90)90409-8
  21. Schmauz R, Okong P, de Villiers EM, Dennin R, Brade L, Lwanga SK, Owor R. Multiple infections in cases of cervical cancer from a high-incidence area in tropical Africa. Int J Cancer. 2989. 43: 805-809. https://doi.org/10.1002/ijc.2910430511
  22. Silins I, Ryd W, Stre A, Wadell G, Tornberg S, Hansson BG. Chlamydia trachomatis infection and persistence of human papillomavirus. Int J Cancer. 2005. 16: 110-115.
  23. Van Der Pol B. Sexually transmitted infections in women. Scand J Clin Lab Invest Suppl. 2014. 244: 68-74. https://doi.org/10.3109/00365513.2014.936691
  24. Werness BA, Levine AJ, Howley PM. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science. 1990. 248: 76-79. https://doi.org/10.1126/science.2157286
  25. Zhang D, Li T, Chen L, Zhang X, Zhao G, Liu Z. Epidemiological investigation of the relationship between common lower genital tract infections and high-risk human papillomavirus infections among women in Beijing. China. PloS One. 2017. 12: e0178033. https://doi.org/10.1371/journal.pone.0178033
  26. zur Hausen. H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer. 2002. 2: 342-350. https://doi.org/10.1038/nrc798
  27. zur Hausen H. Papillomaviruses in the causation of human cancers a brief historical account. Virology. 2009. 384: 260-265. https://doi.org/10.1016/j.virol.2008.11.046